No, as we have never been asked by our members to determine the consensus opinion of our members.
So @Andy, are you saying the s4me board do not think SEID getting its own code is something to be concerned about?
No, as we have never been asked by our members to determine the consensus opinion of our members.
No, I'm not saying that at all. The individual board members will have their own opinions, which they are fully entitled to, which is up to them to reveal, or not.So @Andy, are you saying the s4me board do not think SEID getting its own code is something to be concerned about?
No, I'm not saying that at all. The individual board members will have their own opinions, which they are fully entitled to, which is up to them to reveal, or not.
I can say that the board will not be officially taking a position because it is obvious that there is no consensus opinion among our active members on this subject.
For me, that's important. I think nearly everyone in the ME community who is active online knows the problems and differences of "CFS vs. ME". But most doctors will not. Most doctors won't care. Unless there are guidelines explaining the differences - and giving rules - (at least in Germany) CFS will be diagnozed in 98% of the cases (that is, if it is diagnozed at all).
AFAIK, doctors are often not the ones that pick the actual code. They write a diagnostic term and then medical records coders assign the code. NCHS's point is that if the doctor uses the "SEID" term, then the coders need to be able to assign that code.If a doctor thinks SEID criteria are appropriate, she will use them and just use the existing ME code or the US 'CFS NOS' code. I don't think people will stop using the criteria just because it doesn't have a code. Only a single validated criteria (possibly backed up by biomarkers) will do that.
Definitionally, the CFS criteria never require PEM and other hallmark criteria. But PEM is a hallmark of ME. Because of these definitional differences, the IOM explicitly stated that "a diagnosis of CFS is not equivalent to a diagnosis of ME." In my opinion, to untangle this mess, these two terms need to be separated and there is ample evidence to justify that. In the proposal that Suzy Chapman and I submiitted on ICD-11 for these terms, we recommended that these terms be separated for the same reason.
I really appreciate and share the concern with adding to the existing confusion of terminology. But in the US, medical education providers, at least one medical society, and reportedly some doctors have started to use the term "SEID."
Some people have said that while the term "SEID" was recommended, it was never officially endorsed. HHS itself is using the term "ME/CFS" in its material. But HHS does not have the authority to tell the medical community that they must do so as well. And NCHS, the group managing the ICD-10-CM, has stated that if the term "SEID" is being used by medical providers, then they must provide a code for it.
If a code is to be added, then I'm only aware of two options: 1) equate it to one of the other 5 codes - e.g. CFS or ME or 2) give it a separate and distinct code.
If a code is not added for SEID, then what code do the medical providers use if they are using the term SEID?
IMO, this is complicated mess for which there is no simple solution in the short term.
I hear you but shouldn’t the ME community challenge medical education providers and some doctors doing this? Doctors should be encouraged to use the ME code in the ICD 10 CM. By SEID being given an ICD code this will just cement it further, risk it being used for research and once again ME is sidelined. I think the IOM report made some useful statements but I can’t support the SEID criteria which I know HHS are referring to as now ME/CFS.
This and your previous post are very helpful and, I think, get to the heart of the issue. I wasn't aware that it wasn't doctors who do the coding, but that makes sense.Are you asking whether the community should challenge medical providers not to use the IOM criteria, the SEID name or both?
Regarding the IOM criteria - I know some US patients do not want to see the IOM criteria used but others do support its rollout. I pushed for the CCC multiple times over the years but saw no movement in the medical community. IMO, this is the first time in decades that we've been able to get medical providers to take a fresh look at the disease, to remove recommendations for CBT and GET, to provide definitive statements that the disease is not psychiatric but rather involves neurological, immunological, energy metabolism, and autonomic dysfunction.
Regarding the concern with the criteria used in research - I am also concerned with that issue but its more than just whether the IOM criteria are used there. The position taken when the NIH conducted the CDE effort was that any criteria could be used, including Fukuda. And the specific methods to evaluate those criteria were undefined. In the UK, NICE has been used and while it says it requires PEM, it also states the exacerbation of symptoms post exertion optional so what kind of PEM is that. I dont favor the IOM for use in research but even if its not used, we still have substantial issues in how cohorts are selected for research that must be addressed. Until that happens, we will be comparing apples and oranges.
Edited to add: Regarding use of the IOM criteria - I know some advocates in the US are advocating that CCC also be used and that descriptions of the disease are as encompassing as the CCC. The CFSAC recommendations on the implementation of the IOM criteria were specific on these details as were other efforts which provided feedback and recommendations to the CDC.
Tbh, one of the things that upset me the most was the slide saying the cause was unknown despite a vigorous search, which to me implies more searching is unnecessary.
There hasn’t been such a thorough search that there’s no more need for searching.
That risks suppression of research interest.
Regarding the IOM criteria - I know some US patients do not want to see the IOM criteria used but others do support its rollout. I pushed for the CCC multiple times over the years but saw no movement in the medical community. IMO, this is the first time in decades that we've been able to get medical providers to take a fresh look at the disease, to remove recommendations for CBT and GET, to provide definitive statements that the disease is not psychiatric but rather involves neurological, immunological, energy metabolism, and autonomic dysfunction.
Regarding the concern with the criteria used in research - I am also concerned with that issue but its more than just whether the IOM criteria are used there. The position taken when the NIH conducted the CDE effort was that any criteria could be used, including Fukuda. And the specific methods to evaluate those criteria were undefined. In the UK, NICE has been used and while it says it requires PEM, it also states the exacerbation of symptoms post exertion is optional so what kind of PEM is that? I dont favor the IOM for use in research but even if its not used, we still have substantial issues in how research cohorts are selected that must be addressed. Until that happens, we will be comparing apples and oranges.
Why is the absence of exclusion criteria a problem?
Why is the presence of exclusion criteria a problem?
This is suggesting that the diagnosis of ME should be based on first excluding all other conditions. That's what Fukuda did and that lead to this disease being viewed as a wastebin diagnosis once all the "real" diseases were excluded. IMO, one of the things the IOM did well for clinical diagnosis is to change from a diagnosis by exclusion to a positive diagnosis based on a recognition of hallmark symptoms such as PEM. This does not mean that doctors should not perform a solid differential diagnosis to look for alternative diagnoses that could explain the symptoms. They have to do that and they also need to identify co-morbid conditions. But it would not seem to be a good idea to only diagnose ME once other potential conditions are successfully treated. What if there is no treatment for that other disease?@Medfeb I think some people think if exclusions are allowed then someone with another illness as well as ME would not be able to get a ME diagnosis. However, these could be co morbid diagnoses. If they get treatment for an exclusionary condition and ME symptoms remain then they can still get a ME diagnosis for their ME.
Not sure what you are referring to so maybe I am missing something. But the IOM report based its definition of PEM on at the CCC and stated that PEM was associated with not only an exacerbation of some or all of a patients symptoms but also a further reduction in function. Here's a few statements on what the IOM says about PEMI am also concerned the term post exertional malaise in the SEID criteria is not thorough enough only requiring symptoms to be worse after exertion.
I agree with you that these statements on CDC's website are problematic especially given that doctors still dont get PEM or the associated impairment in energy metabolism. The recommendations for generic sleep hygiene practices are also not appropriate. And there are other issues as well. Advocates continue to push CDC to address this and other issues. Some of these issues have been addressed and others still need to be.You say that the IOM report paved the way for medical advisors to remove recommendations for GET and CBT. However, CDC’s updated webpages on ‘ME/CFS’ to healthcare providers still after acknowledging PEM and people should be cautious with standard exercise programs say at the end of that section “tolerance of aerobic exercise and normal levels of activity is also a long-term goal that can be related to improved function”, so they are still bringing in the idea of increasing aerobic activity (with no medical treatment as there is no recognised FDA treatment currently as we know) ultimately which as we know is massively inappropriate for pwme.
I appreciate that the ICC had not been out for long at the time of the CFSAC recommendation or the letter to HHS from 50 experts calling for the CCC to be used. But I've been at a number of research meetings in the last year or two and many of the researchers stated they are still using CCC, including some who signed that letter. That suggests to me that it was not just a timing issue.Finally, you say you are aware that there are US advocates calling for the Canadian criteria and I read that the CFSAC also recommended them. However, I am aware there are knowledgable US advocates who convincingly argue that the ICC criteria select ME the best and though the CFSAC recommended Canadian criteria for research before and after the IOM developed the SEID criteria this was only because at the time of the IOM assignment ICC had not been out for long so they thought there was more chance of getting the CCC criteria universally accepted which were heading in the right direction and detangling ME from the top broad Fukuda CFS criteria.